Project Grant HT94252410054
Award Date 2/1/24
Completion Date 1/31/26
Dollars Obligated $312K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- The Department of Defense's Defense Health Agency awarded a $1,100,747 Project Grant on April 1, 2025 to the Regents of the University of Michigan to conduct research on "Protein Engineering of Antibody-Drug Conjugates to Coordinate the Innate and Adaptive Immune Systems for Curative Responses" under the Military Medical Research and Development program (CFDA 12.420). This research aims to develop innovative medical solutions that address critical health challenges relevant to military...
- The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
- This $248,156 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Regents of the University of Michigan to identify molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. The award period is from October 1, 2025 to September 30, 2027. As a major research university, the University of Michigan has a diverse portfolio of federal contract and grant awards,...
- The U.S. Defense Health Agency awarded a $405,600 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) with a performance period from August 1, 2025 to July 31, 2027. The grant supports research aimed at repairing retinal damage through the viral-mediated reprogramming of Müller glia cells. As a major research university, the University of Michigan has extensive experience executing federal contracts and grants...
- The University of Michigan received a $932,498 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct non-invasive central nervous system delivery of immunocytokines for sustained expansion of regulatory T cells and treatment of amyotrophic lateral sclerosis (ALS). The award period runs from June 1, 2025 to May 31, 2027. This research aims to develop innovative medical solutions that address critical health...
- The federal Project Grant award of $537,536.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan is funding research to "TARGET MYCOBIOME METABOLISM TO REPROGRAM THE IMMUNOSUPPRESSIVE PANCREATIC TUMOR MICROENVIRONMENT". The award has a performance period from November 1, 2025 to October 31, 2028 and aims to transform healthcare for military service members, veterans, and the broader public...
- This $320,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Regents of the University of Michigan to investigate the impact of the integrated stress response on visual synaptic circuits in multiple sclerosis. The research, to be conducted from September 1, 2025 to August 31, 2027, aims to advance the understanding of disease mechanisms and develop potential therapeutic solutions for this...
- This $780,000 Project Grant was awarded on August 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The grant will support a 3-year research project titled "Lead Exposure and Sex-Specific Programming of Cardiovascular Disease Across the Life Course" focused on advancing biomedical research to transform healthcare for military service members, veterans, and the public. The...
- This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
- This $1,404,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan, Office of Research and Sponsored Projects (doing business as the University of Michigan) on September 1, 2023. The funding will support research to target the lipid kinase PIKfyve in neuroendocrine prostate cancer over a 3-year period ending on August 31, 2026. The University of Michigan is a leading U.S....